One ecosystem for the science of operations.
Best-of-breed products that stand on their own and compose into a single platform. Start with the module you need today and expand across the suite as you grow — without migrating off your data.
What makes it a platform, not a portfolio.
The difference is the core every product shares. Adopt one product and you are already on the foundation for the rest.
Shared data layer
Every product writes to one governed source of truth, so data flows between modules instead of being re-keyed.
Common AI core
The same models for classification, anomaly detection and drafting power every product in the suite.
Unified audit trail
Immutable, inspection-ready logging spans documents, inventory, specimens and clinical operations alike.
The real cost of fragmentation.
Point tools feel cheaper until you add up the re-keying, reconciliation and audit scrambles. A unified platform removes the tax you didn't know you were paying.
- Data re-keyed between disconnected systems
- Reconciling spreadsheets across teams
- Separate audit trails — or none at all
- Multiple vendors, contracts and renewals
- Integrations that break with every update
- Compliance evidence scattered at audit time
- One source of truth across every module
- Data flows automatically between products
- A single, immutable audit trail end to end
- One platform, one relationship, one roadmap
- Native interoperability on a shared core
- Inspection-ready evidence in a few clicks
What teams ask before they switch.
Genuinely integrated. They share a single data layer, AI core and audit trail. A document controlled in ECMS can drive training; inventory in IMS can link to clinical activities; specimens in Biobank connect to studies — all without exports and re-imports.
Start with your most acute pain. Sponsors and CROs usually begin with MAESTRO Clinical Trials; health authorities with IMS; quality-driven organizations with ECMS; translational teams with Biobank. Whichever you pick, you are on the foundation for the rest.
For most Canadian and mid-market organizations, yes — at a fraction of enterprise pricing, with Canadian data residency and bilingual support. We will scope a realistic migration plan based on your current tools and data.
Yes. Our bioinformatics practice builds custom pipelines, analytics platforms and AI models, and we extend the platform with bespoke integrations and workflows where your operations require it.
Ready to build on a unified platform?
Book a discovery call and see how RAN BioLinks can consolidate your research, supply chain and compliance operations into one intelligent system.